Menu
GeneBe

10-100290500-A-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_016112.3(PKD2L1):c.2027T>C(p.Ile676Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000082 ( 0 hom. )

Consequence

PKD2L1
NM_016112.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.808
Variant links:
Genes affected
PKD2L1 (HGNC:9011): (polycystin 2 like 1, transient receptor potential cation channel) This gene encodes a member of the polycystin protein family. The encoded protein contains multiple transmembrane domains, and cytoplasmic N- and C-termini. The protein may be an integral membrane protein involved in cell-cell/matrix interactions. This protein functions as a calcium-regulated nonselective cation channel. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.059486687).
BS2
High AC in GnomAd at 11 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PKD2L1NM_016112.3 linkuse as main transcriptc.2027T>C p.Ile676Thr missense_variant 13/16 ENST00000318222.4
PKD2L1NM_001253837.2 linkuse as main transcriptc.1886T>C p.Ile629Thr missense_variant 13/16

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PKD2L1ENST00000318222.4 linkuse as main transcriptc.2027T>C p.Ile676Thr missense_variant 13/161 NM_016112.3 P1Q9P0L9-1
PKD2L1ENST00000528248.1 linkuse as main transcriptc.*1767T>C 3_prime_UTR_variant, NMD_transcript_variant 13/161
PKD2L1ENST00000465680.2 linkuse as main transcriptc.105-2022T>C intron_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152152
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000200
AC:
5
AN:
250238
Hom.:
0
AF XY:
0.00000739
AC XY:
1
AN XY:
135392
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000821
AC:
12
AN:
1460746
Hom.:
0
Cov.:
31
AF XY:
0.00000826
AC XY:
6
AN XY:
726724
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000722
AC:
11
AN:
152270
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.000241
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000125
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 18, 2023The c.2027T>C (p.I676T) alteration is located in exon 13 (coding exon 13) of the PKD2L1 gene. This alteration results from a T to C substitution at nucleotide position 2027, causing the isoleucine (I) at amino acid position 676 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.28
Cadd
Benign
14
Dann
Benign
0.91
DEOGEN2
Benign
0.26
T
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.73
T
M_CAP
Benign
0.043
D
MetaRNN
Benign
0.059
T
MetaSVM
Benign
-0.66
T
MutationAssessor
Uncertain
2.5
M
MutationTaster
Benign
0.90
N;N;N
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.22
Sift
Benign
0.036
D
Sift4G
Benign
0.080
T
Polyphen
0.0010
B
Vest4
0.17
MVP
0.68
MPC
0.088
ClinPred
0.091
T
GERP RS
1.3
Varity_R
0.12
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143580376; hg19: chr10-102050257; COSMIC: COSV100559406; COSMIC: COSV100559406; API